This document is a publication of a European patent application (EP2024194382A1) from the European Patent Office (EPO). The patent describes methods for preventing or treating neural disorders and/or diseases through the modulation of the plasminogen-plasmin cascade. The application was published on March 18, 2026, and is designated for various European states.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential new therapeutic approaches and intellectual property in the field of neurology and biotechnology, which may be of interest to pharmaceutical and biotechnology companies for research and development or licensing considerations.